Guerbet SA

XPAR:GBT (France)   Ordinary Shares
€ 37.90 (+1.61%) Jun 7
21.42
P/B:
1.24
Market Cap:
€ 477.15M ($ 516.00M)
Enterprise V:
€ 767.97M ($ 830.50M)
Volume:
5.80K
Avg Vol (2M):
14.86K
Also Trade In:
Volume:
5.80K
Avg Vol (2M):
14.86K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Guerbet ( XPAR:GBT ) from 1990 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Guerbet stock (XPAR:GBT) PE ratio as of Jun 08 2024 is 21.42. More Details

Guerbet SA (XPAR:GBT) PE Ratio (TTM) Chart

To

Guerbet SA (XPAR:GBT) PE Ratio (TTM) Historical Data

Total 1280
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Guerbet PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-08 21.7 2024-04-05 19.9
2024-06-07 21.7 2024-04-04 20.1
2024-06-06 21.3 2024-04-03 19.7
2024-06-05 20.7 2024-04-02 18.9
2024-06-04 20.5 2024-03-28 18.8
2024-06-03 20.4 2024-03-27 19.2
2024-05-31 20.8 2024-03-26 19.6
2024-05-30 20.9 2024-03-25 20.3
2024-05-29 20.8 2024-03-22 19.5
2024-05-28 21.2 2024-03-21 17.4
2024-05-27 21.7 2024-03-20 17.3
2024-05-24 21.2 2024-03-19 18.1
2024-05-23 21.4 2024-03-18 18.2
2024-05-22 21.0 2024-03-15 18.0
2024-05-21 20.7 2024-03-14 18.2
2024-05-20 21.0 2024-03-13 18.3
2024-05-17 21.2 2024-03-12 18.1
2024-05-16 20.8 2024-03-11 17.8
2024-05-15 21.3 2024-03-08 18.6
2024-05-14 20.9 2024-03-07 17.9
2024-05-13 21.5 2024-03-06 18.1
2024-05-10 21.7 2024-03-05 17.6
2024-05-09 21.7 2024-03-04 17.7
2024-05-08 21.1 2024-03-01 17.4
2024-05-07 21.3 2024-02-29 17.1
2024-05-06 21.8 2024-02-28 16.9
2024-05-03 21.7 2024-02-27 16.6
2024-05-02 21.9 2024-02-26 16.5
2024-04-30 21.5 2024-02-23 16.7
2024-04-29 21.1 2024-02-22 17.1
2024-04-26 21.4 2024-02-21 16.8
2024-04-25 20.5 2024-02-20 17.5
2024-04-24 20.3 2024-02-19 17.3
2024-04-23 20.1 2024-02-16 16.6
2024-04-22 19.6 2024-02-15 16.7
2024-04-19 19.3 2024-02-14 16.6
2024-04-18 18.9 2024-02-13 16.0
2024-04-17 18.7 2024-02-12 15.7
2024-04-16 18.7 2024-02-09 14.7
2024-04-15 19.5 2024-02-08 13.4
2024-04-12 19.1 2024-02-07 13.3
2024-04-11 19.2 2024-02-06 13.7
2024-04-10 19.0 2024-02-05 13.4
2024-04-09 19.2 2024-02-02 13.2
2024-04-08 19.4 2024-02-01 12.8

Guerbet SA (XPAR:GBT) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.